financetom
Business
financetom
/
Business
/
Tesla Rival Rivian Rolls Out Next-Gen R1S And R1T: Enhanced Performance, Design, And Tech Start At $69,900
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla Rival Rivian Rolls Out Next-Gen R1S And R1T: Enhanced Performance, Design, And Tech Start At $69,900
Jun 6, 2024 12:46 PM

On Thursday, Rivian Automotive, Inc. ( RIVN ) introduced the second generation of its flagship vehicles, R1S and R1T.

The Tesla, Inc. ( TSLA ) rival’s new vehicles will have advanced performance, evolved tech platform, and updated designs, with prices starting at $69,900, according to a press release.

While preserving Rivian’s iconic exterior design, the second generation prioritizes efficiency through a zonal electrical architecture.

“We continue to evolve our flagship R1 vehicles, offering quality and performance without compromise,” said RJ Scaringe, Rivian CEO and founder.

Pricing for the second generation R1S will start at $75,900 and R1T will start at $69,900. Production is based in Normal, Illinois with deliveries available immediately. 

The 1,025 horsepower Quad-Motor R1T delivers 0-60 mph in less than 2.5 seconds and a 1,198lb ft of torque when using Launch Mode.

Also Read: ‘It Needs To End:’ Elon Musk Rages Again Against ‘Corrupted Lie’ Of ESG Scores After Tesla’s Low Rating Puzzles Cathie Wood

Rivian-built dual motors are also available. The company specified that these motors are now designed, engineered, and manufactured fully in-house.

It introduces new compute and autonomy platforms, fresh motor configurations, design elements, and trim and tire options for customers.

“Our revamped R1S and R1T push the technical boundaries further, creating our most capable products to date,” Scaringe added.

Rivian’s next-generation platform introduces a redesigned thermal system with a heat pump, improving rider temperature comfort and saving range, along with new 22-inch aero wheels and tires reducing drag, optimizing range for extended adventures.

Price Action: RIVN shares are trading higher by 2.10% to $11.69 at last check Thursday.

Read Next: Bath & Body Works To See More Comfort In Second Half Numbers With Further Improvement: Analysts

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Boston Scientific lifts annual profit view on steady heart devices demand
Boston Scientific lifts annual profit view on steady heart devices demand
Jul 23, 2025
(Reuters) -Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates. Shares of the Massachusetts-based company rose 2.3% in premarket trading following the results. A rise in surgical procedures has benefited medical device manufacturers such as Boston Scientific, as it boosted sales and helped...
Waldencast to Acquire Novaestiq, US Rights to Saypha Line of Injectable Hyaluronic Acid Gels
Waldencast to Acquire Novaestiq, US Rights to Saypha Line of Injectable Hyaluronic Acid Gels
Jul 23, 2025
07:55 AM EDT, 07/23/2025 (MT Newswires) -- Waldencast ( WALD ) said Wednesday that it has agreed to acquire dermatological firm Novaestiq, as well as the US rights to the Saypha line of hyaluronic acid injectable gels, in a cash-and-stock deal. Waldencast ( WALD ) said it has agreed to acquire Novaestiq in exchange for a combination of upfront cash,...
M/I Homes Q2 Earnings Fall, Revenue Rises
M/I Homes Q2 Earnings Fall, Revenue Rises
Jul 23, 2025
07:57 AM EDT, 07/23/2025 (MT Newswires) -- M/I Homes ( MHO ) reported Q2 earnings Wednesday of $4.42 per diluted share, down from $5.12 a year earlier. Two analysts surveyed by FactSet expected $4.39. Revenue for the quarter ended June 30 was $1.16 billion, up from $1.11 billion a year ago. Three analysts surveyed by FactSet expected $1.12 billion. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved